the psp beverage group showed lower hepatic marker levels than the placebo group during the ingestion period, particularly the ggt level (-14.1 iu/l, 95% confidence intervel (ci) -25.4 to -2.7, p=0.017 at 2 weeks; -16.8 iu/l, 95% ci -36.2 to 2.5, p=0.081 at 4 weeks; -26.7 iu/l, 95% ci -47.6 to -5.7, p=0.014 at 6 weeks and -27.9 iu/l, 95% ci -49.9 to -5.9; p=0.014 at 8 weeks).